Glen Harbor Capital Management’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$721K Buy
13,524
+1,092
+9% +$58.7K 0.02% 573
2019
Q2
$726K Sell
12,432
-4,424
-26% -$238K 0.02% 580
2019
Q1
$836K Buy
16,856
+420
+3% +$18.5K 0.02% 502
2018
Q4
$612K Sell
16,436
-1,232
-7% -$44.8K 0.01% 547
2018
Q3
$667K Buy
17,668
+2,100
+13% +$87.4K 0.01% 599
2018
Q2
$682K Buy
15,568
+2,996
+24% +$141K 0.01% 547
2018
Q1
$633K Buy
12,572
+1,736
+16% +$102K 0.01% 554
2017
Q4
$713K Buy
10,836
+336
+3% +$21.4K 0.02% 532
2017
Q3
$628K Buy
10,500
+840
+9% +$49.9K 0.02% 527
2017
Q2
$626K Sell
9,660
-2,772
-22% -$175K 0.02% 530
2017
Q1
$776K Sell
12,432
-7,896
-39% -$475K 0.02% 454
2016
Q4
$1.17M Buy
+20,328
New +$1.2M 0.03% 349

Other funds holding XRAY

Glen Harbor Capital Management's XRAY Position: Q3 2019 in Review

Glen Harbor Capital Management increased its Dentsply Sirona (XRAY) stake by 8.8% in Q3 2019, buying an estimated $58.7K and bringing the position to 13,524 shares worth $721K. The position accounts for 0.02% of the portfolio, ranked #573.

Glen Harbor Capital Management first reported a position in XRAY in Q4 2016 and has held it in 12 quarters since. The position peaked at $1.17M in Q4 2016. 533 funds tracked by Wall St. Rank hold XRAY as of Q3 2019.

  • Glen Harbor Capital Management held 13,524 shares of Dentsply Sirona worth $721K as of Q3 2019.
  • Glen Harbor Capital Management bought 1,092 Dentsply Sirona shares in Q3 2019, an estimated $58.7K.
  • Dentsply Sirona made up 0.02% of Glen Harbor Capital Management's portfolio in Q3 2019, its #573 holding.
  • Glen Harbor Capital Management first reported a position in Dentsply Sirona in Q4 2016 and has held it in 12 quarters since.
  • Glen Harbor Capital Management's Dentsply Sirona position peaked at $1.17M in Q4 2016.
  • 533 funds tracked by Wall St. Rank held Dentsply Sirona as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.